DT
ELV icon

Diversified Trust’s Elevance Health ELV Stock Holding History

Diversified Trust’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.84M Sell
17,694
-1,393
-7% -$517K 0.11% 105
2026
Q1 		$5.59M Sell
19,087
-16,839
-47% -$5.53M 0.1% 112
2025
Q4 		$12.6M Buy
35,926
+1,775
+5% +$600K 0.23% 52
2025
Q3 		$11M Sell
34,151
-2,058
-6% -$640K 0.22% 59
2025
Q2 		$14.1M Buy
36,209
+9,454
+35% +$3.8M 0.31% 41
2025
Q1 		$11.6M Buy
26,755
+4,179
+19% +$1.68M 0.29% 51
2024
Q4 		$8.33M Buy
22,576
+2,725
+14% +$1.14M 0.2% 63
2024
Q3 		$10.3M Sell
19,851
-52
-0.3% -$27.8K 0.26% 50
2024
Q2 		$10.8M Sell
19,903
-1,841
-8% -$973K 0.3% 44
2024
Q1 		$11.3M Buy
21,744
+1,348
+7% +$670K 0.34% 43
2023
Q4 		$9.62M Buy
20,396
+2,572
+14% +$1.19M 0.32% 43
2023
Q3 		$7.76M Buy
17,824
+3,813
+27% +$1.73M 0.29% 49
2023
Q2 		$6.22M Buy
14,011
+1,330
+10% +$614K 0.23% 55
2023
Q1 		$5.83M Buy
12,681
+973
+8% +$463K 0.23% 57
2022
Q4 		$6.01M Sell
11,708
-206
-2% -$105K 0.25% 58
2022
Q3 		$5.41M Buy
11,914
+6,990
+142% +$3.34M 0.24% 54
2022
Q2 		$2.38M Sell
4,924
-22
-0.4% -$10.9K 0.1% 110
2022
Q1 		$2.43M Buy
4,946
+104
+2% +$47.5K 0.08% 119
2021
Q4 		$2.25M Buy
4,842
+2,001
+70% +$842K 0.07% 135
2021
Q3 		$1.06M Sell
2,841
-955
-25% -$363K 0.04% 217
2021
Q2 		$1.45M Buy
3,796
+725
+24% +$277K 0.05% 180
2021
Q1 		$1.1M Buy
3,071
+139
+5% +$44.7K 0.04% 198
2020
Q4 		$941K Sell
2,932
-222
-7% -$68.1K 0.04% 217
2020
Q3 		$847K Buy
3,154
+1,212
+62% +$326K 0.04% 209
2020
Q2 		$511K Sell
1,942
-283
-13% -$75.5K 0.03% 249
2020
Q1 		$505K Buy
2,225
+39
+2% +$10.6K 0.03% 202
2019
Q4 		$660K Buy
2,186
+1,205
+123% +$332K 0.03% 188
2019
Q3 		$236K Sell
981
-33
-3% -$9.04K 0.01% 311
2019
Q2 		$286K Buy
1,014
+60
+6% +$16.4K 0.01% 286
2019
Q1 		$274K Sell
954
-120
-11% -$34.7K 0.01% 284
2018
Q4 		$282K Buy
1,074
+3
+0.3% +$825 0.02% 256
2018
Q3 		$294K Hold
1,071
– – 0.01% 249
2018
Q2 		$255K Sell
1,071
-72
-6% -$16.7K 0.02% 259
2018
Q1 		$251K Sell
1,143
-608
-35% -$143K 0.02% 256
2017
Q4 		$394K Buy
1,751
+680
+63% +$145K 0.02% 188
2017
Q3 		$203K Hold
1,071
– – 0.02% 275
2017
Q2 		$201K Buy
+1,071
New +$192K 0.02% 285

Other funds holding ELV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MIHAS
Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PAS
Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return

Diversified Trust's ELV Position: Q2 2026 in Review

Diversified Trust reduced its Elevance Health (ELV) stake by 7.3% in Q2 2026, selling an estimated $517K and leaving 17,694 shares worth $6.84M. The position accounts for 0.11% of the portfolio, ranked #105.

Diversified Trust first reported a position in ELV in Q2 2017 and has held it in 37 quarters since. The position peaked at $14.1M in Q2 2025. 222 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Diversified Trust held 17,694 shares of Elevance Health worth $6.84M as of Q2 2026.
  • Diversified Trust sold 1,393 Elevance Health shares in Q2 2026, an estimated $517K.
  • Elevance Health made up 0.11% of Diversified Trust's portfolio in Q2 2026, its #105 holding.
  • Diversified Trust first reported a position in Elevance Health in Q2 2017 and has held it in 37 quarters since.
  • Diversified Trust's Elevance Health position peaked at $14.1M in Q2 2025.
  • 222 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.